WO2009126652A3 - Glycan based array and uses thereof - Google Patents

Glycan based array and uses thereof Download PDF

Info

Publication number
WO2009126652A3
WO2009126652A3 PCT/US2009/039810 US2009039810W WO2009126652A3 WO 2009126652 A3 WO2009126652 A3 WO 2009126652A3 US 2009039810 W US2009039810 W US 2009039810W WO 2009126652 A3 WO2009126652 A3 WO 2009126652A3
Authority
WO
WIPO (PCT)
Prior art keywords
glycan
diseases
therapeutic targets
based array
methods
Prior art date
Application number
PCT/US2009/039810
Other languages
French (fr)
Other versions
WO2009126652A2 (en
Inventor
Huiru Wang
Original Assignee
B&H Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B&H Biotechnologies filed Critical B&H Biotechnologies
Priority to CN200980112434.8A priority Critical patent/CN102016583B/en
Publication of WO2009126652A2 publication Critical patent/WO2009126652A2/en
Publication of WO2009126652A3 publication Critical patent/WO2009126652A3/en
Priority to US12/900,913 priority patent/US9119866B2/en
Priority to US14/803,725 priority patent/US10342812B2/en
Priority to US16/435,098 priority patent/US11285166B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Abstract

The present disclosure discloses simple and efficient glycan- or carbohydrate-based processes or methods for the rapid identification of biological markers and therapeutic targets especially glycan-related targets of infectious diseases, cancers, autoimmune diseases, allergies, inflammation, toxicity, obesity and/or other disorders of humans, animals, plants and other organisms. Therefore, novel methods and products for the diagnosis, prevention, and treatment of such diseases obtainable based on these therapeutic targets can be developed.
PCT/US2009/039810 2008-04-08 2009-04-07 Glycan based array and uses thereof WO2009126652A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN200980112434.8A CN102016583B (en) 2008-04-08 2009-04-07 Glycan based array and uses thereof
US12/900,913 US9119866B2 (en) 2008-04-08 2010-10-08 Glycan-based drugs, therapies and biomarkers
US14/803,725 US10342812B2 (en) 2008-04-08 2015-07-20 Glycan-based drugs, therapies and biomarkers
US16/435,098 US11285166B2 (en) 2008-04-08 2019-06-07 Glycan-based drugs, therapies and biomarkers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4339608P 2008-04-08 2008-04-08
US61/043,396 2008-04-08

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/900,913 Continuation-In-Part US9119866B2 (en) 2008-04-08 2010-10-08 Glycan-based drugs, therapies and biomarkers

Publications (2)

Publication Number Publication Date
WO2009126652A2 WO2009126652A2 (en) 2009-10-15
WO2009126652A3 true WO2009126652A3 (en) 2009-12-30

Family

ID=41162557

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/039810 WO2009126652A2 (en) 2008-04-08 2009-04-07 Glycan based array and uses thereof

Country Status (2)

Country Link
CN (1) CN102016583B (en)
WO (1) WO2009126652A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102507920A (en) * 2011-09-30 2012-06-20 西安交通大学 Lectin chip and application thereof
CN103131208A (en) * 2013-02-01 2013-06-05 刘中路 Coloring sterilization ointment for anatomic marks in clinical laboratory
EP3001837A4 (en) * 2013-03-15 2017-05-17 Huiru Wang Biological therapeutics for infection-relating disorders or conditions
CN103901212B (en) * 2014-03-28 2015-07-22 西北大学 Glycan microarray for identifying serial liver diseases based on saliva glycan-binding proteins, and application of glycan microarray
WO2016026143A1 (en) 2014-08-22 2016-02-25 Huiru Wang Saccharide-based biomarkers and therapeutics
CN104237448B (en) * 2014-10-09 2016-08-24 成都中医药大学 The thin layer detection method of Radix Anisodi Tangutici root
CN105255868B (en) * 2015-10-23 2018-04-20 广西壮族自治区农业科学院经济作物研究所 Identify bar horse fire fiber crops property method for distinguishing and its molecular labeling, primer pair and kit
FR3044680B1 (en) * 2015-12-02 2017-12-22 Univ Limoges METHOD OF DETECTING CANCER STEM CELLS
CN108003228A (en) * 2018-01-12 2018-05-08 渤海大学 A kind of ginger glycoprotein with ACE inhibitory activity
JP7324998B2 (en) * 2018-04-25 2023-08-14 パナソニックＩｐマネジメント株式会社 SENSOR SUBSTRATE, SENSOR SUBSTRATE MANUFACTURING METHOD, AND DETECTION DEVICE
CN109580953B (en) * 2018-11-16 2021-11-05 山西省食品药品检验所(山西省药品包装材料监测中心) Detection device for spearmint colloidal gold doped in mint and mint decoction pieces, preparation method and application
WO2022040090A1 (en) * 2020-08-17 2022-02-24 The Regents Of The University Of California Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259142A1 (en) * 2003-06-04 2004-12-23 Imperial College Innovations Limited Products and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1156703C (en) * 2001-11-08 2004-07-07 郭占军 Bio-chemical protein chip and its preparing process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259142A1 (en) * 2003-06-04 2004-12-23 Imperial College Innovations Limited Products and methods

Also Published As

Publication number Publication date
WO2009126652A2 (en) 2009-10-15
CN102016583A (en) 2011-04-13
CN102016583B (en) 2017-05-10

Similar Documents

Publication Publication Date Title
WO2009126652A3 (en) Glycan based array and uses thereof
EP3299387A3 (en) Identification of tumor-associated markers for diagnosis and therapy
WO2010057112A3 (en) Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets
WO2009072604A1 (en) Anti-nr10 antibody and use thereof
WO2004065423A3 (en) Recognition molecules for the treatment and detection of tumours
WO2012038068A8 (en) Means and methods for the prediction of treatment response of a cancer patient
WO2007007173A3 (en) Human anti-madcam antibodies
EP2433962A3 (en) Identification of tumor-associated antigens for diagnosis and therapy
BRPI0815175A2 (en) A device and procedure for the diagnosis or preparation of the diagnosis and / or monitoring of therapy for inflammatory diseases such as rheumatoid arthritis.
WO2007141278A3 (en) Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
WO2006107947A3 (en) Hyperspectral imaging in diabetes and peripheral vascular disease
WO2006099610A3 (en) Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy
WO2010004590A3 (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
WO2007121124A3 (en) Hcv inhibitors comprising beta amino acids and their uses
WO2007121125A3 (en) Hcv inhibitors
WO2009105590A3 (en) Identification of pediatric onset inflammatory bowel disease loci and methods of use thereof for the diagnosis and treatment of the same
WO2015019195A3 (en) Systems, devices, and methods for deploying onboard reagents in a diagnostic device
WO2008066576A3 (en) Methods for screening antimicrobial and antiviral compounds and uses thereof
WO2007109733A3 (en) Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2007084625A3 (en) Novel compounds and methods for inhibiting p53 activity
WO2009068682A3 (en) Phenyl-oxetanyl-derivatives
AP2012006180A0 (en) Picrorhiza kurroa extract for prevention, elimination and treatment of RNA viruses and infection or diseases caused by the same in humans, animals andin biotech industry.
WO2008021493A3 (en) A process for identification of molecular mimicry and the uses thereof
WO2016096640A3 (en) Anti-cxcl12 antibody molecules and their uses
WO2007141005A8 (en) Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980112434.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09730803

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09730803

Country of ref document: EP

Kind code of ref document: A2